BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12025827)

  • 21. Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
    Gelenberg AJ; Trivedi MH; Rush AJ; Thase ME; Howland R; Klein DN; Kornstein SG; Dunner DL; Markowitz JC; Hirschfeld RM; Keitner GI; Zajecka J; Kocsis JH; Russell JM; Miller I; Manber R; Arnow B; Rothbaum B; Munsaka M; Banks P; Borian FE; Keller MB
    Biol Psychiatry; 2003 Oct; 54(8):806-17. PubMed ID: 14550680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nefazodone treatment of major depression in alcohol-dependent patients: a double-blind, placebo-controlled trial.
    Roy-Byrne PP; Pages KP; Russo JE; Jaffe C; Blume AW; Kingsley E; Cowley DS; Ries RK
    J Clin Psychopharmacol; 2000 Apr; 20(2):129-36. PubMed ID: 10770449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Faster remission of chronic depression with combined psychotherapy and medication than with each therapy alone.
    Manber R; Kraemer HC; Arnow BA; Trivedi MH; Rush AJ; Thase ME; Rothbaum BO; Klein DN; Kocsis JH; Gelenberg AJ; Keller ME
    J Consult Clin Psychol; 2008 Jun; 76(3):459-67. PubMed ID: 18540739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which depressed patients respond to nefazodone and when?
    Trivedi MH; Rush AJ; Pan JY; Carmody TJ
    J Clin Psychiatry; 2001 Mar; 62(3):158-63. PubMed ID: 11305700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group Cognitive Behavioural Analysis System of Psychotherapy (CBASP) for persistently depressed outpatients: a retrospective chart review.
    Potijk MR; Aan Het Rot M; Parlevliet FM; Schoevers RA; Eldering MJ
    Br J Clin Psychol; 2020 Nov; 59(4):552-564. PubMed ID: 32920864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of childhood maltreatment on the differential efficacy of CBASP versus escitalopram in patients with chronic depression: A secondary analysis.
    Bausch P; Fangmeier T; Zobel I; Schoepf D; Drost S; Schnell K; Walter H; Berger M; Normann C; Schramm E
    Clin Psychol Psychother; 2017 Sep; 24(5):1155-1162. PubMed ID: 28326653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
    Nemeroff CB; Heim CM; Thase ME; Klein DN; Rush AJ; Schatzberg AF; Ninan PT; McCullough JP; Weiss PM; Dunner DL; Rothbaum BO; Kornstein S; Keitner G; Keller MB
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14293-6. PubMed ID: 14615578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nefazodone in patients with treatment-refractory posttraumatic stress disorder.
    Zisook S; Chentsova-Dutton YE; Smith-Vaniz A; Kline NA; Ellenor GL; Kodsi AB; Gillin JC
    J Clin Psychiatry; 2000 Mar; 61(3):203-8. PubMed ID: 10817106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relation between changes in patients' interpersonal impact messages and outcome in treatment for chronic depression.
    Constantino MJ; Laws HB; Arnow BA; Klein DN; Rothbaum BO; Manber R
    J Consult Clin Psychol; 2012 Jun; 80(3):354-64. PubMed ID: 22545738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of nefazodone on women with seasonal affective disorder: clinical and polysomnographic analyses.
    Shen J; Kennedy SH; Levitan RD; Kayumov L; Shapiro CM
    J Psychiatry Neurosci; 2005 Jan; 30(1):11-6. PubMed ID: 15644992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptom clusters as predictors of late response to antidepressant treatment.
    Trivedi MH; Morris DW; Grannemann BD; Mahadi S
    J Clin Psychiatry; 2005 Aug; 66(8):1064-70. PubMed ID: 16086624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K; Schweizer E; Case WG; DeMartinis N; Greenblatt DJ; Mandos LA; Garcia EspaƱa FG
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nefazodone in social phobia.
    Van Ameringen M; Mancini C; Oakman JM
    J Clin Psychiatry; 1999 Feb; 60(2):96-100. PubMed ID: 10084635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized controlled trial on the efficacy of mindfulness-based cognitive therapy and a group version of cognitive behavioral analysis system of psychotherapy for chronically depressed patients.
    Michalak J; Schultze M; Heidenreich T; Schramm E
    J Consult Clin Psychol; 2015 Oct; 83(5):951-63. PubMed ID: 26371617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dropouts versus completers among chronically depressed outpatients.
    Arnow BA; Blasey C; Manber R; Constantino MJ; Markowitz JC; Klein DN; Thase ME; Kocsis JH; Rush AJ
    J Affect Disord; 2007 Jan; 97(1-3):197-202. PubMed ID: 16857266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Mindfulness-Based Cognitive Therapy and Cognitive Behavioral Analysis System of Psychotherapy added to Treatment as Usual on suicidal ideation in chronic depression: Results of a randomized-clinical trial.
    Forkmann T; Brakemeier EL; Teismann T; Schramm E; Michalak J
    J Affect Disord; 2016 Aug; 200():51-7. PubMed ID: 27128357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.
    Kocsis JH; Gelenberg AJ; Rothbaum BO; Klein DN; Trivedi MH; Manber R; Keller MB; Leon AC; Wisniewski SR; Arnow BA; Markowitz JC; Thase ME;
    Arch Gen Psychiatry; 2009 Nov; 66(11):1178-88. PubMed ID: 19884606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic reactance as a predictor of outcome in the treatment of chronic depression.
    Arnow BA; Manber R; Blasey C; Klein DN; Blalock JA; Markowitz JC; Rothbaum BO; Rush AJ; Thase ME; Riso LP; Vivian D; McCullough JP; Keller MB
    J Consult Clin Psychol; 2003 Dec; 71(6):1025-35. PubMed ID: 14622078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.